Peter Radovich Net Worth & Insider Trades

Peter Radovich - See Remarks, Global Blood Therapeutics, Inc

As of February 16, 2018

What is Peter Radovich's Net Worth?

The current estimated net worth of Global Blood Therapeutics, Inc's See Remarks, Peter Radovich, is estimated to be about $3.45M . Peter Radovich owns about 6,817 units of Global Blood Therapeutics, Inc common stock. In the last 2 years at Global Blood Therapeutics, Inc, Peter Radovich has sold an estimated value of $3.35M worth.

What is Peter Radovich's Past Insider Trading?

Peter Radovich's largest purchase order was 12,500 units , worth over $250K on January 7, 2016. Peter Radovich's largest sale order was 30,000 units , worth over $1.8M on January 25, 2018. In total, Peter Radovich has made about 16 transactions over 2 years of their time at Global Blood Therapeutics, Inc. Peter Radovich usually trades in January, with the busiest year in 2018. The most recent transaction was a sale order of 2,404 units , worth over $140.47K on February 2, 2018.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was Peter Radovich's Salary in 2020?

As See Remarks of Global Blood Therapeutics, Inc, Peter Radovich has a total base salary of $277,992 . Peter Radovich received compensation valued at about $2,644,820 in 2020 after becoming See Remarks. The vast majority of their compensation came in the form of a bonus of $111,197 , option awards of $2,255,631 ,

What is Peter Radovich's' Mailing Address?

  • Mailing address is C/o Global Blood Therapeutics, Inc. 400 East Jamie Court, Suite 101 South San Francisco CA 94080 CA

Global Blood Therapeutics, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Ted Love, M.D. 2020 $661,250 - $11,778,840 $4,693,666 $467,000 $5,000 $17,605,756
Ted Love, M.D. 2019 $596,876 - $4,359,600 $4,595,717 $540,000 $5,000 $10,097,193
Ted Love, M.D. 2018 $568,750 - $4,648,800 $4,623,690 $414,000 $5,000 $10,260,240
David Johnson 2020 $463,750 - $4,037,361 $1,582,504 $234,000 $5,000 $6,322,615
David Johnson 2019 $453,125 - $1,211,000 $1,267,784 $250,000 $5,000 $3,186,909
David Johnson 2018 $355,000 $75,000 $1,897,750 $1,898,534 $169,000 $5,000 $4,394,284
Jeffrey Farrow 2020 $457,813 - $3,708,261 $1,582,504 $231,500 $5,000 $5,985,078
Jeffrey Farrow 2019 $440,625 - $1,211,000 $1,267,784 $244,000 $5,000 $3,168,409
Jeffrey Farrow 2018 $425,938 - $1,370,800 $1,326,469 $201,000 $5,000 $3,329,207
Jung Choi 2020 $433,125 - $3,708,261 $1,582,504 $219,000 $5,000 $5,947,890
Jung Choi 2019 $416,875 - $1,211,000 $1,267,784 $231,000 $5,000 $3,131,659
Jung Choi 2018 $392,063 - $1,370,800 $1,326,469 $185,000 $5,000 $3,279,332
Tricia Suvari 2020 $422,499 - $3,708,261 $1,582,504 $214,000 $5,000 $5,932,264
Tricia Suvari 2019 $403,125 - $1,211,000 $1,267,784 $223,000 $5,000 $3,109,909
Tricia Suvari 2018 $386,875 - $1,549,600 $1,515,964 $183,000 $5,000 $3,640,439
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1629137/000119312521136815/d97499ddef14a.htm

What are Global Blood Therapeutics, Inc's Past Insider Trades?

Global Blood Therapeutics, Inc's most recent insider trade came on June 22, 2022 by Philip Pizzo who sold 1,260 units worth $34.34K . In the last 7 years, insiders at Global Blood Therapeutics, Inc have sold an estimated value of $163.83M and bought an estimated value of $15.46M worth of shares. Insider trading is most common in June, with the busiest year in 2020. The most active traders at the company are Jung Choi, See Remarks,  Ted Love, President and CEO,  and Borga Tricia Suvari, Chief Legal Officer .

Global Blood Therapeutics, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1